EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients. FRANKLIN LAKES, N.J. and SÃO PAULO, July 29, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),...
Covered in this story
What has happened since
- Becton Dickinson is up 15.1% since this was published, 83 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $BDX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Becton Dickinson →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.